AI-powered clinical decision support platform that detects time-sensitive conditions and coordinates care teams.
| Industry | Healthcare Technology |
| Stage | Series E |
| IPO Status | Pre-IPO |
| Valuation | $1.2B |
| Total Funding | $310M |
| Headquarters | San Francisco, CA |
| CEO | Chris Mansi |
Viz.ai is valued at $1.2B as of June 2022.
Viz.ai is currently classified as pre-IPO. No S-1 has been publicly filed. Monitor TechStackIPO for the latest IPO status updates.
Viz.ai has raised $310M in total venture capital funding.
Viz.ai is a Healthcare Technology company. AI-powered clinical decision support platform that detects time-sensitive conditions and coordinates.
Viz.ai scores 70/100 on TechStackIPO's IPO readiness index, which evaluates funding stage, valuation trajectory, S-1 filing status, and market timing signals.